These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36505354)

  • 1. Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus.
    Jin LS; Ke JY; Lin YN; Li L; Fu JY; Chen YL; Qiu YX; Li XW; Pan YQ; Li YC
    Front Cardiovasc Med; 2022; 9():1071119. PubMed ID: 36505354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage closure in patients with left atrial appendage thrombus guided by intracardiac echocardiography.
    Wang B; Chu H; Wang Z; Fu G; Yu Y; Feng M; Du X
    Heart Rhythm; 2024 Jun; 21(6):812-818. PubMed ID: 38272283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure.
    Zhang Z; Zhou J; Lin Q; Wang C; Huang Y; Dai Y; Zuo W; Liu N; Xiao Y; Liu Q
    BMC Cardiovasc Disord; 2024 Mar; 24(1):175. PubMed ID: 38515032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and clinical impact of peridevice leak following left atrial appendage closure with the LAmbre device-Data from a prospective multicenter clinical study.
    Wang G; Kong B; Qin T; Liu Y; Huang C; Huang H
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):354-359. PubMed ID: 33251673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of left atrial appendage orifice diameter on the safety and efficacy of left atrial appendage closure using the LAmbre device.
    Zhuo W; Wang B; Fu G; Yu Y; Feng M; Liu J; Du X; Chu H
    J Formos Med Assoc; 2024 May; 123(5):600-605. PubMed ID: 38238125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should left atrial appendage closure be considered in resistant left atrial appendage thrombus cases? 'Former Foe, New Ally'.
    Ates AH; Kivrak A; Karakulak UN; Coteli C; Yorgun H; Sahiner ML; Barıs Kaya E; Aytemir K
    Pacing Clin Electrophysiol; 2024 Apr; 47(4):583-590. PubMed ID: 38477017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Left Atrial Appendage Closure with the LAmbre Device Protected by a Cerebral Protection System in a 76-Year-Old Man with Persistent Left Atrial Appendage Thrombus.
    Popescu SȘ; Heeger CH; Keelani A; Tilz RR
    Am J Case Rep; 2022 Sep; 23():e937063. PubMed ID: 36101478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Safety and Efficacy of Percutaneous Left Atrial Appendage Closure with the LAmbre Device.
    Wang G; Kong B; Liu Y; Huang H
    J Interv Cardiol; 2020; 2020():6613683. PubMed ID: 33424491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and Safety of Left Atrial Appendage Closure Using the LAmbre Device in Patients with Nonvalvular Atrial Fibrillation with or Without Prior Catheter Ablation.
    Feng XF; Zhang PP; Sun J; Wang QS; Li YG
    Int Heart J; 2019 Jan; 60(1):63-70. PubMed ID: 30464131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices.
    Ke JY; Jin LS; Lin YN; Xu J; Liu WK; Fu JY; Li L; Chen YL; Qiu YX; Li YC
    Front Cardiovasc Med; 2022; 9():1011037. PubMed ID: 36407450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Appendage Closure with a New Occluder Device: Efficacy, Safety and Mid-Term Performance.
    Llagostera-Martín M; Cubero-Gallego H; Mas-Stachurska A; Salvatella N; Sánchez-Carpintero A; Tizon-Marcos H; Garcia-Guimaraes M; Calvo-Fernandez A; Molina L; Vaquerizo B
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33915971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
    Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness.
    Llagostera-Martín M; Cainzos M; Salvatella N; Cubero-Gallego H; Mas-Stachurska A; Sánchez-Carpintero A; Tizón-Marcos H; Calvo-Fernández A; Molina L; Vaquerizo B
    Rev Esp Cardiol (Engl Ed); 2024 Feb; 77(2):150-157. PubMed ID: 37879431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous left atrial appendage closure in the presence of thrombus: A feasibility report.
    Bordignon S; Bologna F; Chen S; Konstantinou A; Tsianakas N; Tohoku S; Trolese L; Chun KJ; Schmidt B
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2858-2863. PubMed ID: 31638713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.
    Asmarats L; Masson JB; Pagnotta PA; Cook S; Foresti M; Ibrahim R; Sukiennik A; Sabiniewicz R; Maffeo D; Carballo J; Cruz-González I; Grasso C; Pisano F; Senatore G; Tarantini G; Kasongo A; Chiarito M; Puricel S; Messas N; Moreno-Samos JC; O'Hara G; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Oct; 11(19):1932-1941. PubMed ID: 30249439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: Initial results from a prospective cohort registry study.
    Chen S; Schmidt B; Bordignon S; Bologna F; Nagase T; Tsianakas N; Perrotta L; Chun KRJ
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):291-297. PubMed ID: 29149516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of left atrial appendage closure using cerebral protection system for thrombosis: no patient left behind.
    Limite LR; Radinovic A; Cianfanelli L; Altizio S; Peretto G; Frontera A; D'Angelo G; Baratto F; Marzi A; Ancona F; Ingallina G; Capogrosso C; Stella S; Melillo F; Agricola E; Della Bella P; Mazzone P
    Pacing Clin Electrophysiol; 2022 Jan; 45(1):23-34. PubMed ID: 34841552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
    J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage.
    Hutt E; Wazni OM; Saliba WI; Kanj M; Tarakji KG; Aguilera J; Barakat AF; Rasmussen P; Uchino K; Russman A; Hussain S; Wisco D; Kapadia S; Lindsay BD; Hussein AA
    Heart Rhythm; 2019 May; 16(5):663-668. PubMed ID: 30521942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.